Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Demchev, Valeriy ^a   Malana, Geraldine ^a   Vangala, Divya ^a   Stoll, Janis ^a   Desai, Anal ^a   Kang, Hye Won ^a   Li, Yingxia ^a   Nayeb Hashemi, Hamed ^a   Niepel, Michele ^a   Cohen, David E ^a   Ukomadu, Chinweike ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN LIKE PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; ENERGY METABOLISM; ENERGY SUBSTRATE UTILIZATION; FEMALE; FGL1 GENE; GENE; GENE DELETION; GLUCONEOGENESIS; HYPERGLYCEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER INJURY; LIVER REGENERATION; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRAIN DIFFERENCE; WHITE ADIPOSE TISSUE; WILD TYPE;

ADIPOSE TISSUE, BROWN; ANIMALS; BODY WEIGHT; CALORIMETRY, INDIRECT; CHOLESTEROL; ENERGY METABOLISM; FASTING; FATTY ACIDS, NONESTERIFIED; FEEDING BEHAVIOR; FIBRINOGEN; GENE DELETION; GENE TARGETING; GLUCOSE; HYPERGLYCEMIA; LIPIDS; LIVER; MICE; MICE, KNOCKOUT; ORGAN SIZE;

EID: 84874611589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058084     Document Type: Article

References (35)

1. Yamamoto T, Gotoh M, Sasaki H, Terada M, Kitajima M, et al. (1993) Molecular cloning and initial characterization of a novel fibrinogen-related gene, HFREP-1. Biochem Biophys Res Commun 193: 681-687.
2. Hara H, Uchida S, Yoshimura H, Aoki M, Toyoda Y, et al. (2000) Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration. Biochim Biophys Acta 1492: 31-44.
3. Hara H, Yoshimura H, Uchida S, Toyoda Y, Aoki M, et al. (2001) Molecular cloning and functional expression analysis of a cDNA for human hepassocin, a liver-specific protein with hepatocyte mitogenic activity. Biochim Biophys Acta 1520: 45-53.
4. Liu Z, Ukomadu C, (2008) Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant. Biochem Biophys Res Commun 365: 729-734.
5. Rijken DC, Dirkx SP, Luider TM, Leebeek FW, (2006) Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clot. Biochem Biophys Res Commun 350: 191-194.
6. Li CY, Cao CZ, Xu WX, Cao MM, Yang F, et al. (2010) Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure. Gut 59: 817-826.
7. Yan J, Ying H, Gu F, He J, Li YL, et al. (2002) Cloning and characterization of a mouse liver-specific gene mfrep-1, up-regulated in liver regeneration. Cell Res 12: 353-361.
8. Taub R, (2004) Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5: 836-847.
9. Yu HT, Yu M, Li CY, Zhan YQ, Xu WX, et al. (2009) Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma. J Biol Chem 284: 13335-13347.
10. Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, et al. (2002) Angptl3 regulates lipid metabolism in mice. Nat Genet 30: 151-157.
11. Koster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, et al. (2005) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146: 4943-4950.
12. Kersten S, Mandard S, Tan NS, Escher P, Metzger D, et al. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 275: 28488-28493.
13. Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, et al. (2002) ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 277: 33742-33748.
14. Lichtenstein L, Berbee JF, van Dijk SJ, van Dijk KW, Bensadoun A, et al. (2007) Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol 27: 2420-2427.
15. Kersten S, (2005) Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 33: 1059-1062.
16. Shimamura M, Matsuda M, Kobayashi S, Ando Y, Ono M, et al. (2003) Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun 301: 604-609.
17. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, et al. (2009) Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10: 178-188.
18. Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, et al. (2005) Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med 11: 400-408.
19. Chu J, Loughlin EA, Gaur NA, Senbanerjee S, Jacob V, et al. (2012) UHRF1 phosphorylation by Cyclin A2/CDK2 is required for zebrafish embryogenesis. Mol Biol Cell.
20. Ukomadu C, Dutta A, (2003) Inhibition of cdk2 activating phosphorylation by mevastatin. J Biol Chem 278: 4840-4846.
21. Sadler KC, Krahn KN, Gaur NA, Ukomadu C, (2007) Liver growth in the embryo and during liver regeneration in zebrafish requires the cell cycle regulator, uhrf1. Proc Natl Acad Sci U S A 104: 1570-1575.
22. Hyogo H, Roy S, Paigen B, Cohen DE, (2002) Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem 277: 34117-34124.
23. Wallace TM, Levy JC, Matthews DR, (2004) Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495.
24. Kam I, Lynch S, Svanas G, Todo S, Polimeno L, et al. (1987) Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology 7: 362-366.
25. Simek J, Melka J, Lejsek K, (1966) Free fatty acids in the blood serum and lipolytic activity of adipose tissue of rats of different age following partial hepatectomy. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 9: 579-580.
26. Ziouzenkova O, Perrey S, Asatryan L, Hwang J, MacNaul KL, et al. (2003) Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase. Proc Natl Acad Sci U S A 100: 2730-2735.
27. Ruby MA, Goldenson B, Orasanu G, Johnston TP, Plutzky J, et al. (2010) VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids. J Lipid Res 51: 2275-2281.
28. Brown JD, Oligino E, Rader DJ, Saghatelian A, Plutzky J, (2011) VLDL hydrolysis by hepatic lipase regulates PPARdelta transcriptional responses. PLoS One 6: e21209.
29. Carvalho E, Kotani K, Peroni OD, Kahn BB, (2005) Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 289: E551-561.
30. Kotani K, Peroni OD, Minokoshi Y, Boss O, Kahn BB, (2004) GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J Clin Invest 114: 1666-1675.
31. German JP, Thaler JP, Wisse BE, Oh IS, Sarruf DA, et al. (2010) Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 152: 394-404.
32. Miyoshi H, Souza SC, Endo M, Sawada T, Perfield JW 2nd, et al (2010) Perilipin overexpression in mice protects against diet-induced obesity. J Lipid Res 51: 975-982.
33. Vallerand AL, Perusse F, Bukowiecki LJ, (1990) Stimulatory effects of cold exposure and cold acclimation on glucose uptake in rat peripheral tissues. Am J Physiol 259: R1043-1049.
34. Shibata H, Perusse F, Vallerand A, Bukowiecki LJ, (1989) Cold exposure reverses inhibitory effects of fasting on peripheral glucose uptake in rats. Am J Physiol 257: R96-101.
35. de Jesus LA, Carvalho SD, Ribeiro MO, Schneider M, Kim SW, et al. (2001) The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 108: 1379-1385.